Panbela Therapeutics organizacji FCF yield
Jaka jest wartość FCF yield organizacji Panbela Therapeutics?
Wartość FCF yield organizacji Panbela Therapeutics Inc. to -2,192.33%
Jaka jest definicja FCF yield?
Free cash flow yield (FCF yield) is a financial ratio that compares the free cash flow per share to the market value per share. The ratio is calculated by dividing free cash flow per share by the current share price.
ttm (trailing twelve months)
Free cash flow yield is a good measure of the company’s cash flow in respect to the company’s size. Larger companies tend to have a higher cash flow yield, but it’s not always the case. The higher the free cash flow yield, the more cash the company is generating that can be quickly accessed to satisfy its obligations. The lower the free cash flow yield, the more money investors are putting into the company with little result. The higher the ratio, the more attractive the investment is as it suggests that investors are paying less for each unit of free cash flow.
Free cash flow acts as an indicator of how capable a company is of repaying all of its obligations. It is a solid indicator of how financially stable a company is. It is calculated as:
Free cash flow yield = Free cash flow per share / market price per share
FCF yield firm w Health Care sektor na NASDAQ w porównaniu do Panbela Therapeutics
Czym się zajmuję organizacja Panbela Therapeutics?
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
Firmy z fcf yield podobne do Panbela Therapeutics
- Wartość FCF yield organizacji Touchpoint to -2,790.72%
- Wartość FCF yield organizacji Valeritas to -2,715.90%
- Wartość FCF yield organizacji Rhino Resource Partners LP to -2,676.97%
- Wartość FCF yield organizacji CARBO Ceramics to -2,674.78%
- Wartość FCF yield organizacji Shiloh Industries to -2,671.82%
- Wartość FCF yield organizacji Briggs & Stratton to -2,633.23%
- Wartość FCF yield organizacji Panbela Therapeutics to -2,192.33%
- Wartość FCF yield organizacji KKR & Co to -2,145.36%
- Wartość FCF yield organizacji Endologix to -1,961.27%
- Wartość FCF yield organizacji Basler Aktiengesellschaft to -1,839.17%
- Wartość FCF yield organizacji Zovio Inc to -1,838.52%
- Wartość FCF yield organizacji PhaseBio Pharmaceuticals to -1,833.88%
- Wartość FCF yield organizacji Tailored Brands to -1,823.08%